Delivery Order SPE2DB22D2206-SPE2DB24FHW90
Award Date
6/24/24
Potential Completion Date
7/16/24
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $19,999.44, is for the provision of the pharmaceutical product PADCEV 30 MG VIALS to the Defense Logistics Agency (DLA). The contract is a Delivery Order issued under the company's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at up to $14,999.58, is for the delivery of 4565092788 PADCEV 30 MG VIALS. This is a firm fixed-price delivery order contract with a completion date of July 29, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has received numerous federal contract awards to supply...
The U.S. Department of Defense (DoD) Defense Logistics Agency (DLA) awarded a $24,999.30 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of PADCEV 30 MG vials, a pharmaceutical product, with a period of performance through October 28, 2024. AmerisourceBergen is a large pharmaceutical distributor that provides a wide range of medical commodities to federal agencies, including the military. This contract...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was made by the Defense Logistics Agency (DLA) on June 25, 2024. The $41,647.50 firm fixed-price delivery order is for the supply of PADCEV 30 MG vials, with a completion date of July 17, 2024. The contract is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $116,823.84, is for the delivery of PADCEV 30 MG VIALS, a specialty pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 14, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,345.32, is for the delivery of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply PADCEV 30 MG Vials. The contract has a firm fixed price of $11,087.60 and a performance period ending on July 14, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,195.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products...
This federal contract award, valued at $2,665.17, was issued by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for Prime Vendor Pharmaceutical Branch-Philadelphia, with a firm fixed price structure and an ultimate completion date of July 27, 2022. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution...
The U.S. government has awarded a Delivery Order contract worth $14,852.63 to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to federal agencies. This contract, which has a ceiling value of $14,852.63 and an ultimate completion date of July 2, 2024, is a Firm Fixed Price contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen also...